acrosstheveil
Senior Member
- Messages
- 375
How would you go about treating these mutations? How much methylfolate woudl some require compared to someone who is homozygous c677t?
First of all, being heterozygous for both is only worse than being heterozygous for C677T if each bad allele comes from a different parent. If both alleles are from the same parent (on the same strand), then MTHFR activity is at 65% of normal. If each allele is from a different parent, then MTHFR activity is 30% of normal.How would you go about treating these mutations? How much methylfolate woudl some require compared to someone who is homozygous c677t?
First of all, being heterozygous for both is only worse than being heterozygous for C677T if each bad allele comes from a different parent. If both alleles are from the same parent (on the same strand), then MTHFR activity is at 65% of normal. If each allele is from a different parent, then MTHFR activity is 30% of normal.
I don't think a dose over 400-800mcg is typically advocated, unless there's additional evidence of a problem with actual methylfolate levels. If interested in going higher, you really need to talk to a doctor about that.
The important thing is that you can't use folic acid very effectively. So any supplementing should be done with methylfolate. Alternatively, eating a diet with lots of veggies has the same compensatory effect as supplementing.[/q......................................................................................................................................................... Can you explain the "different vs same" parent source a littler further. also the 30% of normal function seems to be the same as a ++C677T situation.? I assumed compound +/- had better function than that. Do you have any cites for this ?. ( Note:always enjoy your answers)
From what I recall, if both mutations are on the same strand (from the same parent) the other strand can do all of the work and keep things going at a normal level. Whereas if both strands have a mutation, the reduction in functionality is going to have an impact.Can you explain the "different vs same" parent source a littler further. also the 30% of normal function seems to be the same as a ++C677T situation.? I assumed compound +/- had better function than that. Do you have any cites for this ?
Amazing answer! thanks. The visualization of you typing with a catheter sticking out of your hand and answering some anonymous "schmuck" four thousand miles away is breathtaking. Only on a CFS/ME website! GoodluckFrom what I recall, if both mutations are on the same strand (from the same parent) the other strand can do all of the work and keep things going at a normal level. Whereas if both strands have a mutation, the reduction in functionality is going to have an impact.
I can't do much citing at the moment. I've got a catheter sticking out of my hand so much typing is difficult, and getting a fever and such from the IV antibiotics. Not really up for going hunting! But I am quite sure that the studies I read showed that the compound heterozygous was as bad as being homozygous for C677T.
The only sources I have saved currently are http://digitalcommons.unl.edu/lawfacpub/124 for C677T (A222V) and http://www.snpedia.com/index.php/Rs1801131 has a good summary of and links to the sources for A1298C (E429A).
This from Ben Lynch:
He wanted me to drop back to 400mcg based on my compound hetero status and go no higher than 1600mcg if I really felt I needed to push it higher. I seem to be doing best at about 800mcg, and I am taking 1 mg subdermal mb12 shots every other day (with 5mg sublingual tabs on the off days, plus 3-5 mg sublingual Adenosylcobalamin every day (estimating at best 25 percent absorption of the sublinguals.)
He claims "For starters, geneticists have looked at thousands of people for these two DNA polymorphisms. What they discovered was that if one copy of the MTHFR gene had C677T, it would rarely have A1298C also." but fails to provide any link to the claimed evidence.Just to clearify this for everybody, I read somewhere that there is a greater odds of beeing compound heterozygous for C677T and A1298C than not beeing it. It has to do with something that these two poly's came from two different persons back in time.
Just to clarify ... they're saying that having both mutations on the same strand (from the same parent) is uncommon. Being compound heterozygous, on the other hand, means having each mutation on a different strand.I find it very odd that these two parents should be compound if being compund should be that rare in the population.